BlackRock’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.43M | Sell |
2,211,316
-145,496
|
|
||||
|
2025
Q1 | $6.2M | Buy |
2,356,812
+73,639
|
|
||||
|
2024
Q4 | $8.08M | Buy |
2,283,173
+429,424
|
|
||||
|
2024
Q3 | $8.45M | Buy |
1,853,749
+85,080
|
|
||||
|
2024
Q2 | $7.69M | Sell |
1,768,669
-32,941
|
|
||||
|
2024
Q1 | $9.04M | Sell |
1,801,610
-61,829
|
|
||||
|
2023
Q4 | $11.7M | Buy |
1,863,439
+134,319
|
|
||||
|
2023
Q3 | $12.3M | Sell |
1,729,120
-308
|
|
||||
|
2023
Q2 | $17.6M | Buy |
1,729,428
+1,617,539
|
|
||||
|
2023
Q1 | $1.01M | Buy |
111,889
+47,727
|
|
||||
|
2022
Q4 | $460K | Sell |
64,162
-640
|
|
||||
|
2022
Q3 | $422K | Buy |
64,802
+14
|
|
||||
|
2022
Q2 | $313K | Buy |
64,788
+6,905
|
|
||||
|
2022
Q1 | $329K | Sell |
57,883
-1,602
|
|
||||
|
2021
Q4 | $298K | Buy |
59,485
+1,380
|
|
||||
|
2021
Q3 | $387K | Sell |
58,105
-4,092
|
|
||||
|
2021
Q2 | $380K | Sell |
62,197
-266,972
|
|
||||
|
2021
Q1 | $2.19M | Buy |
329,169
+6,866
|
|
||||
|
2020
Q4 | $1.71M | Buy |
322,303
+62,827
|
|
||||
|
2020
Q3 | $1.93M | Buy |
259,476
+1,116
|
|
||||
|
2020
Q2 | $1.9M | Buy |
258,360
+238,148
|
|
||||
|
2020
Q1 | $150K | Buy |
20,212
+316
|
|
||||
|
2019
Q4 | $112K | Buy |
19,896
+2,306
|
|
||||
|
2019
Q3 | $104K | Sell |
17,590
-990
|
|
||||
|
2019
Q2 | $60K | Sell |
18,580
-326,307
|
|
||||
|
2019
Q1 | $1.03M | Sell |
344,887
-13,356
|
|
||||
|
2018
Q4 | $1.35M | Buy |
358,243
+7,094
|
|
||||
|
2018
Q3 | $2.06M | Buy |
351,149
+3,063
|
|
||||
|
2018
Q2 | $1.97M | Buy |
348,086
+59,617
|
|
||||
|
2018
Q1 | $3.58M | Buy |
288,469
+287,105
|
|
||||
|
2017
Q4 | $16K | Buy |
+1,364
|
|